The FDA approves Shire's (SHPGY.PK) Lialda for patients with ulcerative colitis. Shares -0.4% in...

|By:, SA News Editor

The FDA approves Shire's (SHPGY.PK) Lialda for patients with ulcerative colitis. Shares -0.4% in London trading.